J. R. Dispirito and D. Mathis, Immunological contributions to adipose tissue homeostasis, Seminars in Immunology, vol.27, issue.5, pp.315-336, 2015.
DOI : 10.1016/j.smim.2015.10.005

D. L. Morris, K. Singer, and C. N. Lumeng, Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states, Current Opinion in Clinical Nutrition and Metabolic Care, vol.14, issue.4, pp.341-347, 2011.
DOI : 10.1097/MCO.0b013e328347970b
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690541

A. Chawla, K. D. Nguyen, and Y. P. Goh, Macrophage-mediated inflammation in metabolic disease, Nature Reviews Immunology, vol.17, issue.11, pp.738-787, 2011.
DOI : 10.1038/nm.2353
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383854

E. Dalmas, K. Clement, and M. Guerre-millo, Defining macrophage phenotype and function in adipose tissue, Trends in Immunology, vol.32, issue.7, pp.307-321, 2011.
DOI : 10.1016/j.it.2011.04.008

M. Kratz, Metabolic Dysfunction Drives a Mechanistically Distinct Proinflammatory Phenotype in Adipose Tissue Macrophages, Cell Metabolism, vol.20, issue.4, pp.614-639, 2014.
DOI : 10.1016/j.cmet.2014.08.010

T. Suganami, J. Nishida, and Y. Ogawa, A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor ??, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.10, pp.2062-2070, 2005.
DOI : 10.1161/01.ATV.0000183883.72263.13

P. A. Permana, C. Menge, and P. Reaven, Macrophage-secreted factors induce adipocyte inflammation and insulin resistance, Biochemical and Biophysical Research Communications, vol.341, issue.2, pp.507-514, 2006.
DOI : 10.1016/j.bbrc.2006.01.012

C. N. Lumeng, S. M. Deyoung, and A. R. Saltiel, Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins, AJP: Endocrinology and Metabolism, vol.292, issue.1, pp.166-74, 2007.
DOI : 10.1152/ajpendo.00284.2006

D. Lacasa, S. Taleb, M. Keophiphath, A. Miranville, and K. Clement, Macrophage-Secreted Factors Impair Human Adipogenesis: Involvement of Proinflammatory State in Preadipocytes, Endocrinology, vol.148, issue.2, pp.868-877, 2007.
DOI : 10.1210/en.2006-0687
URL : https://hal.archives-ouvertes.fr/inserm-00126603

M. Keophiphath, Macrophage-Secreted Factors Promote a Profibrotic Phenotype in Human Preadipocytes, Molecular Endocrinology, vol.23, issue.1, pp.11-24, 2009.
DOI : 10.1210/me.2008-0183

O. Hara, A. Lim, F. L. Mazzatti, D. J. Trayhurn, and P. , Stimulation of inflammatory gene expression in human preadipocytes by macrophage-conditioned medium: upregulation of IL-6 production by macrophage-derived IL-1beta, Mol Cell Endocrinol, vol.349, pp.239-286, 2012.

D. Gao, Interleukin-1?? mediates macrophage-induced impairment of insulin signaling in human primary adipocytes, AJP: Endocrinology and Metabolism, vol.307, issue.3, pp.289-304, 2014.
DOI : 10.1152/ajpendo.00430.2013

G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, vol.259, issue.5091, pp.87-91, 1993.
DOI : 10.1126/science.7678183

G. S. Hotamisligil, Inflammation and metabolic disorders, Nature, vol.314, issue.7121, pp.860-867, 2006.
DOI : 10.1074/jbc.M411860200

F. C. Mcgillicuddy, Lack of Interleukin-1 Receptor I (IL-1RI) Protects Mice From High-Fat Diet-Induced Adipose Tissue Inflammation Coincident With Improved Glucose Homeostasis, Diabetes, vol.60, issue.6, pp.1688-98, 2011.
DOI : 10.2337/db10-1278

C. Cavelti-weder, Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes, Diabetes Care, vol.35, issue.8, pp.1654-62, 2012.
DOI : 10.2337/dc11-2219

C. Lagathu, Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone, Biochemical and Biophysical Research Communications, vol.311, issue.2, pp.372-381, 2003.
DOI : 10.1016/j.bbrc.2003.10.013

V. Rotter, I. Nagaev, and U. Smith, Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-?, Overexpressed in Human Fat Cells from Insulin-resistant Subjects, Journal of Biological Chemistry, vol.10, issue.46, pp.45777-84, 2003.
DOI : 10.1038/nm724

J. P. Bastard, Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.9, pp.3338-3380, 2000.
DOI : 10.1210/jc.85.9.3338

V. Bourlier, TGFbeta Family Members Are Key Mediators in the Induction of Myofibroblast Phenotype of Human Adipose Tissue Progenitor Cells by Macrophages, PLoS ONE, vol.29, issue.2, p.31274, 2012.
DOI : 10.1371/journal.pone.0031274.s001
URL : https://hal.archives-ouvertes.fr/inserm-00726178

A. Bertola, Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients, Diabetes, vol.61, issue.9, pp.2238-2285, 2012.
DOI : 10.2337/db11-1274
URL : https://hal.archives-ouvertes.fr/inserm-00726176

E. Fabbrini, Association Between Specific Adipose Tissue CD4+ T-Cell Populations and Insulin Resistance in Obese Individuals, Gastroenterology, vol.145, issue.2, pp.366-374, 2013.
DOI : 10.1053/j.gastro.2013.04.010
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756481

E. Dalmas, T Cell-Derived IL-22 Amplifies IL-1??-Driven Inflammation in Human Adipose Tissue: Relevance to Obesity and Type 2 Diabetes, Diabetes, vol.63, issue.6, pp.1966-77, 2014.
DOI : 10.2337/db13-1511

C. Lagathu, Long-term treatment with interleukin-1? induces insulin resistance in murine and human adipocytes, Diabetologia, vol.50, issue.Suppl 3, pp.2162-73, 2006.
DOI : 10.1152/ajpendo.00110.2003

J. Jager, T. Gremeaux, M. Cormont, L. Marchand-brustel, Y. Tanti et al., Interleukin-1?-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression, Endocrinology, vol.148, issue.1, pp.241-51, 2007.
DOI : 10.1210/en.2006-0692
URL : https://hal.archives-ouvertes.fr/inserm-00139856

Z. Wang, High Fat Diet Induces Formation of Spontaneous Liposarcoma in Mouse Adipose Tissue with Overexpression of Interleukin 22, PLoS ONE, vol.290, issue.8, p.23737, 2011.
DOI : 10.1371/journal.pone.0023737.g006

X. Wang, Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes, Nature, vol.118, pp.237-278, 2014.
DOI : 10.1371/journal.ppat.1003539

L. A. Zuniga, IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity, The Journal of Immunology, vol.185, issue.11, pp.6947-59, 2010.
DOI : 10.4049/jimmunol.1001269
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001125

M. Ahmed and S. L. Gaffen, IL-17 inhibits adipogenesis in part via C/EBP?, PPAR? and Kr?ppel-like factors, Cytokine, vol.61, issue.3, pp.898-905, 2013.
DOI : 10.1016/j.cyto.2012.12.007
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595389

C. Rouault, Roles of Chemokine Ligand-2 (CXCL2) and Neutrophils in Influencing Endothelial Cell Function and Inflammation of Human Adipose Tissue, Endocrinology, vol.154, issue.3, pp.1069-79, 2013.
DOI : 10.1210/en.2012-1415

V. Pellegrinelli, C. Rouault, N. Veyrie, K. Clement, and D. Lacasa, Endothelial Cells From Visceral Adipose Tissue Disrupt Adipocyte Functions in a Three-Dimensional Setting: Partial Rescue by Angiopoietin-1, Diabetes, vol.63, issue.2, pp.535-584, 2014.
DOI : 10.2337/db13-0537

S. Reggio, Increased Basement Membrane Components in Adipose Tissue During Obesity: Links With TGF? and Metabolic Phenotypes, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.6, p.20154304, 2016.
DOI : 10.1210/jc.2015-4304

C. A. Dinarello, S. O. Marnoy, and L. J. Rosenwasser, Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1, J Immunol, vol.130, pp.890-895, 1983.

A. Weber, P. Wasiliew, and M. Kracht, Interleukin-1beta (IL-1beta) processing pathway, Sci Signal, vol.3, p.2, 2010.

M. Lamkanfi and V. M. Dixit, Mechanisms and Functions of Inflammasomes, Cell, vol.157, issue.5, pp.1013-1035, 2014.
DOI : 10.1016/j.cell.2014.04.007

H. Guo, J. B. Callaway, and J. P. Ting, Inflammasomes: mechanism of action, role in disease, and therapeutics, Nature Medicine, vol.34, issue.7, pp.677-87, 2015.
DOI : 10.1016/j.immuni.2011.02.006

K. A. Cho, J. W. Suh, K. H. Lee, J. L. Kang, and S. Woo, IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1? by keratinocytes via the ROS-NLRP3-caspase-1 pathway, International Immunology, vol.24, issue.3, pp.147-58, 2012.
DOI : 10.1093/intimm/dxr110

A. Divoux, Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass Loss, Diabetes, vol.59, issue.11, pp.2817-2842, 2010.
DOI : 10.2337/db10-0585
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963540

M. S. Wilson, Bleomycin and IL-1??mediated pulmonary fibrosis is IL-17A dependent, The Journal of Experimental Medicine, vol.279, issue.3, pp.535-52, 2010.
DOI : 10.4049/jimmunol.180.1.655
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839145

S. Mi, Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF-??1-Dependent and -Independent Mechanisms, The Journal of Immunology, vol.187, issue.6, pp.3003-3017, 2011.
DOI : 10.4049/jimmunol.1004081

M. Tohyama, increased IL-22 receptor expression, European Journal of Immunology, vol.113, issue.10, pp.2779-88, 2009.
DOI : 10.4049/jimmunol.173.11.6712